Title – Immunotherapy in Prostate Cancer
Speaker – Silke Gillessen Sommer, Senior Consultant & Professor, Manchester Cancer Research Centre
Venue – Weston Park Hospital Lecture Theatre (First Floor), Whitham Road, Sheffield S10 2SJ
Time – 14:00 – 15:00, Friday, 18 January 2019
Silke Gillessen Sommer, MD, is a senior consultant, specialising in genitourinary tumors, at the MCRC, The University of Manchester. Previously, she worked as senior consultant in the Department of Oncology/Hematology at Kantonsspital St. Gallen, St. Gallen, Switzerland, where she also head the Clinical Trial Unit. Prof. Gillessen Sommer received her medical degree from the University of Basel, Switzerland. She completed a postdoctoral fellowship in the Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA, USA, before joining Kantonsspital St. Gallen as a consultant in 2001.
Since 1995, Dr. Gillessen Sommer has served as an investigator or principle investigator for multiple phase I, II, and III clinical trials, including “first-in-man” trials. She has published work in leading journals, including Clinical Cancer Research, Journal of National Cancer Institute, Clinical Genitourinary Cancer, European Journal of Cancer, European Urology, Journal of Clinical Oncology, Lancet, New England Institute of Medicine and Annals of Oncology. Her awards include the Byk-Preis, the SIAK/ESSEX Prize and the SAKK/PFIZER Award. She served/serves on the ESMO Scientific Subcommittees for GU Oncology 2014-2017 and was chair of this Committee for Prostate Cancer for ESMO 2018.
She is a founder and organizer of the St.Gallen Advanced Prostate Cancer Consensus Conference (APCCC) held in 2015 and 2017, planned for 2019. She was nominated 2016/2017/2018
For catering purposes, please confirm your attendance to Laura Williams (email@example.com) as soon as possible.